Literature DB >> 25823766

Rapid, accurate, and on-site detection of C. difficile in stool samples.

Marije K Bomers1, Frederik P Menke1, Richard S Savage2, Christina M J E Vandenbroucke-Grauls3, Michiel A van Agtmael1, James A Covington4, Yvo M Smulders1.   

Abstract

OBJECTIVES: A rapid test to diagnose Clostridium difficile infection (CDI) on hospital wards could minimize common but critical diagnostic delay. Field asymmetric ion mobility spectrometry (FAIMS) is a portable mass spectrometry instrument that quickly analyses the chemical composition of gaseous mixtures (e.g., above a stool sample). Can FAIMS accurately distinguish C. difficile-positive from -negative stool samples?
METHODS: We analyzed 213 stool samples with FAIMS, of which 71 were C. difficile positive by microbiological analysis. The samples were divided into training, test, and validation samples. We used the training and test samples (n=135) to identify which sample characteristics discriminate between positive and negative samples, and to build machine learning algorithms interpreting these characteristics. The best performing algorithm was then prospectively validated on new, blinded validation samples (n=78). The predicted probability of CDI (as calculated by the algorithm) was compared with the microbiological test results (direct toxin test and culture).
RESULTS: Using a Random Forest classification algorithm, FAIMS had a high discriminatory ability on the training and test samples (C-statistic 0.91 (95% confidence interval (CI): 0.86-0.97)). When applied to the blinded validation samples, the C-statistic was 0.86 (0.75-0.97). For samples analyzed ≤7 days of collection (n=76), diagnostic accuracy was even higher (C-statistic: 0.93 (0.85-1.00)). A cutoff value of 0.32 for predicted probability corresponded with a sensitivity of 92.3% (95% CI: 77.4-98.6%) and specificity of 86.0% (78.3-89.3%). For even fresher samples, discriminatory ability further increased.
CONCLUSIONS: FAIMS analysis of unprocessed stool samples can differentiate between C. difficile-positive and -negative samples with high diagnostic accuracy.

Entities:  

Mesh:

Year:  2015        PMID: 25823766     DOI: 10.1038/ajg.2015.90

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Recognition of anaerobic bacterial isolates in vitro using electronic nose technology.

Authors:  A Pavlou; A P F Turner; N Magan
Journal:  Lett Appl Microbiol       Date:  2002       Impact factor: 2.858

Review 2.  Exhaled biomarkers.

Authors:  Sergei A Kharitonov; Peter J Barnes
Journal:  Chest       Date:  2006-11       Impact factor: 9.410

3.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Authors:  Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

Review 4.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease.

Authors:  Catherine E Garner; Stephen Smith; Ben de Lacy Costello; Paul White; Robert Spencer; Chris S J Probert; Norman M Ratcliffe
Journal:  FASEB J       Date:  2007-02-21       Impact factor: 5.191

6.  Reducing delays in the diagnosis and treatment of Clostridium difficile diarrhoea.

Authors:  M B Frenz; A S McIntyre
Journal:  QJM       Date:  2003-08

7.  Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach.

Authors:  Carlene A Muto; Mary Kathleen Blank; Jane W Marsh; Emanuel N Vergis; Mary M O'Leary; Kathleen A Shutt; Anthony W Pasculle; Marian Pokrywka; Juliet G Garcia; Kathy Posey; Terri L Roberts; Brian A Potoski; Gary E Blank; Richard L Simmons; Peter Veldkamp; Lee H Harrison; David L Paterson
Journal:  Clin Infect Dis       Date:  2007-10-09       Impact factor: 9.079

Review 8.  The scent of colorectal cancer: detection by volatile organic compound analysis.

Authors:  Nanne K H de Boer; Tim G J de Meij; Frank A Oort; Ilhame Ben Larbi; Chris J J Mulder; Adriaan A van Bodegraven; Marc P van der Schee
Journal:  Clin Gastroenterol Hepatol       Date:  2014-05-10       Impact factor: 11.382

9.  Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.

Authors:  M Westhoff; P Litterst; L Freitag; W Urfer; S Bader; J-I Baumbach
Journal:  Thorax       Date:  2009-01-21       Impact factor: 9.139

Review 10.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

View more
  10 in total

1.  Diagnosis of Clostridium difficile infection using an UPLC-MS based metabolomics method.

Authors:  Pengcheng Zhou; Ning Zhou; Li Shao; Jianzhou Li; Sidi Liu; Xiujuan Meng; Juping Duan; Xinrui Xiong; Xun Huang; Yuhua Chen; Xuegong Fan; Yixiang Zheng; Shujuan Ma; Chunhui Li; Anhua Wu
Journal:  Metabolomics       Date:  2018-07-19       Impact factor: 4.290

2.  Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds.

Authors:  Daniel J C Berkhout; Hendrik J Niemarkt; Marc A Benninga; Andries E Budding; Anton H van Kaam; Boris W Kramer; Charlene M Pantophlet; Mirjam M van Weissenbruch; Nanne K H de Boer; Tim G J de Meij
Journal:  Pediatr Res       Date:  2017-11-22       Impact factor: 3.756

Review 3.  Identification of volatile compounds from bacteria by spectrometric methods in medicine diagnostic and other areas: current state and perspectives.

Authors:  Nils Kunze-Szikszay; Maximilian Euler; Thorsten Perl
Journal:  Appl Microbiol Biotechnol       Date:  2021-08-20       Impact factor: 4.813

4.  In vitro detection of common rhinosinusitis bacteria by the eNose utilising differential mobility spectrometry.

Authors:  Jussi Virtanen; Lauri Hokkinen; Markus Karjalainen; Anton Kontunen; Risto Vuento; Jura Numminen; Markus Rautiainen; Niku Oksala; Antti Roine; Ilkka Kivekäs
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-24       Impact factor: 2.503

5.  Effects of Sampling Conditions and Environmental Factors on Fecal Volatile Organic Compound Analysis by an Electronic Nose Device.

Authors:  Daniel J C Berkhout; Marc A Benninga; Ruby M van Stein; Paul Brinkman; Hendrik J Niemarkt; Nanne K H de Boer; Tim G J de Meij
Journal:  Sensors (Basel)       Date:  2016-11-23       Impact factor: 3.576

6.  Equivalent Performance of the Cobas® Cdiff Test for Use on the Cobas® Liat® System and the Cobas® 4800 System.

Authors:  Sachin K Garg; Kyle Lu; John Duncan; Lance R Peterson; Oliver Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-12-05

Review 7.  Application of Electronic-Nose Technologies and VOC-Biomarkers for the Noninvasive Early Diagnosis of Gastrointestinal Diseases .

Authors:  Alphus Dan Wilson
Journal:  Sensors (Basel)       Date:  2018-08-09       Impact factor: 3.576

8.  Faecal volatile biomarkers of Clostridium difficile infection.

Authors:  Mitesh Patel; Dawn Fowler; Jeremy Sizer; Christopher Walton
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

Review 9.  The Antimicrobial Stewardship Approach to Combating Clostridium Difficile.

Authors:  Eric Wenzler; Surafel G Mulugeta; Larry H Danziger
Journal:  Antibiotics (Basel)       Date:  2015-06-17

10.  Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry.

Authors:  Sofie Bosch; Sofia El Manouni El Hassani; James A Covington; Alfian N Wicaksono; Marije K Bomers; Marc A Benninga; Chris J J Mulder; Nanne K H de Boer; Tim G J de Meij
Journal:  Anal Chem       Date:  2018-06-15       Impact factor: 6.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.